|
Post by itellthefuture777 on Oct 2, 2017 16:48:32 GMT -5
...back then Al said he wouldn't sell for $125 a share...he said analyst were off by orders of magnitude...he said..Afrezza was purhaps the largest pharma opportunity in the history of pharma....Al's IQ was 176..and straight as an arrow. If Al said this is it...this is..it! I remember analyst saying this was a steal under $10 x 5 $50..It's definitely undervalued...but now that chain is off..hmmm up! There has been a heck of a lot of dilution since then as well as shrinking of the pipeline. Back then there was promising oncology division. So unfortunately, what Al said way back then about share price can't be applied to the current situation. I think he would tell you..the same thing he said back then..
|
|
|
Post by dreamboatcruise on Oct 2, 2017 16:56:34 GMT -5
There has been a heck of a lot of dilution since then as well as shrinking of the pipeline. Back then there was promising oncology division. So unfortunately, what Al said way back then about share price can't be applied to the current situation. I think he would tell you..the same thing he said back then.. No... Al actually knew the difference between share price and market cap. As stated, he was damn smart (someone I had the pleasure of meeting way back). Only someone that doesn't understand fundamental business and accounting ideas would make the mistake of assuming that market cap potential magically increases as dilution occurs and assets are sold off. That was not Al.
|
|
|
Post by ghochr on Oct 2, 2017 16:57:38 GMT -5
If you are a large pharma you just pay up if you want something and fight the board just like Sanofi did with xtandi and Pfizer bought ultimately. With proven sales.
They have all the time to wait if they are interested in Afrezza to post 100,s million of dollars in sales.
But right now they only have 15 mil in sales for the second half by Mike. So if you and I can say peak sales of Afrezza is in billions but we don’t have billions to buy Mannkind unfortunately. But the ones that do I would like to know what’s their peak sales at are for Afrezza
|
|
|
Post by itellthefuture777 on Oct 2, 2017 17:06:11 GMT -5
I think he would tell you..the same thing he said back then.. No... Al actually knew the difference between share price and market cap. As stated, he was damn smart (someone I had the pleasure of meeting way back). Only someone that doesn't understand fundamental business and accounting ideas would make the mistake of assuming that market cap potential magically increases as dilution occurs and assets are sold off. That was not Al. ..Let me remind you ..that was $125 x 5..or $625 now...So..even at todays post split $125 is significantly below Al's initial statement...but maybe he foresaw that..hmm
|
|
|
Post by dreamboatcruise on Oct 2, 2017 17:09:43 GMT -5
No... Al actually knew the difference between share price and market cap. As stated, he was damn smart (someone I had the pleasure of meeting way back). Only someone that doesn't understand fundamental business and accounting ideas would make the mistake of assuming that market cap potential magically increases as dilution occurs and assets are sold off. That was not Al. ..Let me remind you ..that was $125 x 5..or $625 now...So..even at todays post split $125 is significantly below Al's initial statement...but maybe he foresaw that..hmm I'm fully aware of our history and rev split... no need for reminding... some I might like to forget, I doubt that's going to happen.
|
|
|
Post by itellthefuture777 on Oct 2, 2017 17:14:36 GMT -5
..Let me remind you ..that was $125 x 5..or $625 now...So..even at todays post split $125 is significantly below Al's initial statement...but maybe he foresaw that..hmm I'm fully aware of our history and rev split... no need for reminding... some I might like to forget, I doubt that's going to happen. I don't...superior insulin..monopoly globally inhaled monomeric..streamlined robotic factory..Once they make enough for 2 million people at $4 billion a year..the valuation can ne 22x or more...also..going global might want to have a modular factory in that country..GCON and Pfizer have that going on..hmm
|
|
|
Post by cjc04 on Oct 2, 2017 18:11:06 GMT -5
Oh I love where this conversation is going.....
I can remember when my greatest worry was Danbury not being able to keep up with demand and how it would look bad on the company. ☺️
AND,,, I love talking about where the market cap should be....
SO,,, what are the #'s?? How much can 3 lines produce running 24/7?
|
|
|
Post by dreamboatcruise on Oct 2, 2017 18:14:51 GMT -5
Oh I love where this conversation is going..... I can remember when my greatest worry was Danbury not being able to keep up with demand and how it would look bad on the company. ☺️ AND,,, I love talking about where the market cap should be.... SO,,, what are the #'s?? How much can 3 lines produce running 24/7? Yes, undoubtedly Mike is kept up nights worrying about being swamped with too many orders to handle. [sarcasm off]
|
|
|
Post by lennymnkd on Oct 2, 2017 18:32:48 GMT -5
As mentioned before / by who I forgot .. why isn't monomeric highlighted in the labeling in every which way ! Is it that that science is just understood ! Find that hard to believe . That person suggested/ THE ONLY MONOMERIC INSULIN ON THE SHELF , to differentiate itself .. what am I missing in what could be a great marketing opportunity.
|
|
|
Post by dreamboatcruise on Oct 2, 2017 18:41:38 GMT -5
As mentioned before / by who I forgot .. why isn't monomeric highlighted in the labeling in every which way ! Is it that that science is just understood ! Find that hard to believe . That person suggested/ THE ONLY MONOMERIC INSULIN ON THE SHELF , to differentiate itself .. what am I missing in what could be a great marketing opportunity. Your missing that a vast majority of people wouldn't have a clue what that means.
|
|
|
Post by lennymnkd on Oct 2, 2017 18:44:53 GMT -5
How about peaking the interest of medical professionals... ? Maybe from what I gather from board conversations , would they even care .. maybe I'm still naive about the whole thing . Seems a shame.
|
|
|
Post by dreamboatcruise on Oct 2, 2017 18:49:28 GMT -5
How about peaking the interest of medical professionals... ? Next time you go to your doctor ask them if they are excited about monomeric insulins... I think you'll get your answer.
|
|
|
Post by letitride on Oct 2, 2017 19:03:26 GMT -5
How about peaking the interest of medical professionals... ? Maybe from what I gather from board conversations , would they even care .. maybe I'm still naive about the whole thing . Seems a shame. Doctors jump on monomeric and it is usually the way I lead them into the PK/PD only to top it off with by the way its inhaled.
|
|
|
Post by letitride on Oct 2, 2017 19:13:47 GMT -5
How about peaking the interest of medical professionals... ? Next time you go to your doctor ask them if they are excited about monomeric insulins... I think you'll get your answer. Theres nothing like the real thing. Pretty much why everything else is just smoke and mirrors. If AL was still around he would have probably engineered a way to administer it 24/7 with the help of a CGM
|
|
|
Post by sayhey24 on Oct 2, 2017 19:21:43 GMT -5
Oh I love where this conversation is going..... I can remember when my greatest worry was Danbury not being able to keep up with demand and how it would look bad on the company. ☺️ AND,,, I love talking about where the market cap should be.... SO,,, what are the #'s?? How much can 3 lines produce running 24/7? They can produce about $1.8B. It will take 2 years to qualify an additional line. After today's news MNKD has never been in a better position to start thinking about expansion. In addition to the label and the dud of a partner in Sanofi, MNKD faced the three year wait for the community to see what issues would arise from early users including all the lung FUD. I would say afrezza has exceeded all expectations and the biggest issue has been PWDs not using enough at meals. I was expecting some improvement in the label but not the full inclusion of the numbers which sets afrezza apart from all other diabetes treatments and obsoletes all RAA's. In all my years following MNKD this was my first pleasant surprise.
|
|